Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6952-61
Subpotent Drug
| Recalling firm | Major Pharmaceuticals |
|---|---|
| Reason | Subpotent Drug |
| Risk class | Class II (Class II · moderate) |
| Status | Ongoing |
| Report date | Jul 29, 2026 |
| Initiated | Jul 13, 2026 |
| Region | OH, United States |
| Distribution | Nationwide in the USA. |
| Quantity | N/A |
| Code/Lot | Lot #: N02310, Exp. Date 01/2027 |
| Type | Voluntary: Firm initiated |
| Recall number | D-0703-2026 |
Official source
U.S. FDA — Recalls, Market Withdrawals & Safety Alerts fda.gov ↗You can re-verify each item on the official FDA site using its recall number. (Recall number: D-0703-2026)
openFDA (U.S. Food & Drug Administration) — food/drug/device enforcement · CC0 1.0 (public domain)
Find out more
- Search this recall on FDA fda.gov ↗
- Search related news (Google News) news.google.com ↗
- Search this product (Google) google.com ↗
The links above open external searches by recall number / product name; the results are the responsibility of each site.
This page summarizes U.S. FDA data for general information and is not medical advice. Confirm details via official FDA announcements and the manufacturer.